Upfront Immunotherapy for Metastatic Kidney Cancer
0 Ansichten
• 06/26/23
0
0
Einbetten
administrator
Abonnenten
Panelists Robert A. Figlin, MD, and Eric Jonasch, MD, provide insight on the implications of frontline trials for immunotherapy and cabozantinib use, and the rationale for combination trials for metastatic kidney cancer.
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare